Direct Detection and Quantification of Transition Metal Ions in Human Atherosclerotic Plaques: Evidence for the Presence of Elevated Levels of Iron and Copper

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 5, 2004, Pages 949-954

  Stadler, Nadina ^a   Lindner, Robyn A ^a,b   Davies, Michael J ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

^b Proteome Systems Ltd   (Australia)

Author keywords

Atherosclerosis; Copper; EPR; Free radicals; Iron; Oxidation

Indexed keywords

CALCIUM; CHOLESTEROL; COPPER COMPLEX; FREE RADICAL; HEME DERIVATIVE; IRON COMPLEX; PROTEIN; TRANSITION ELEMENT;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE COURSE; ELECTRON SPIN RESONANCE; EX VIVO STUDY; HUMAN; HUMAN TISSUE; INTIMA; IRON STORAGE; MASS SPECTROMETRY; MINIMALLY INVASIVE MEASUREMENT; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

AGED; AGED, 80 AND OVER; AORTA; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CHOLESTEROL; COPPER; CORONARY ARTERY BYPASS; ELECTRON SPIN RESONANCE SPECTROSCOPY; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; IRON; MALE; MAMMARY ARTERIES; MASS SPECTROMETRY; MIDDLE AGED; RADIAL ARTERY; TUNICA INTIMA;

EID: 2442563696     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000124892.90999.cb     Document Type: Article

References (50)

1. Heinecke JW. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis. 1998;141:1-15.
2. Folcik VA, Nivar-Aristy RA, Krajewski LP, Cathcart MK. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J Clin Invest. 1995;96:504-510.
3. Leeuwenburgh C, Hardy MM, Hazen SL, Wagner P, Oh-ishi S, Steinbrecher UP, Heinecke JW. Reactive nitrogen intermediates promote low-density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem. 1997;272:1433-1436.
4. Hazell LJ, Arnold L, Flowers D, Waeg G, Malle E, Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest. 1996;97:1535-1544.
5. Hazen SL. Heinecke JW. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalysed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest. 1997;99:2075-2081.
6. Fu S, Davies MJ, Stocker R, Dean RT. Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem J. 1998;333:519-525.
7. Davies MJ, Fu S, Wang H, Dean RT. Stable markers of oxidant damage to proteins and their application in the study of human disease. Free Radic Biol Med. 1999;27:1151-1163.
8. Hunter GC, Dubick MA, Keen CL, Eskelson CD. Effects of hypertension on aortic antioxidant status in human aneurysmal and occlusive disease. Proc Soc Exp Biol Med. 1991;196:273-279.
9. Smith C, Mitchinson MJ, Aruoma OI, Halliwell B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J. 1992;286:901-905.
10. Pallon J, Knox J, Forslind B, Werner-Linde Y, Pinheiro T: Applications in medicine using the new Lund microprobe. Nucl Instr Meth. 1993;B77:287-293.
11. Swain J, Gutteridge JMC. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material. FEBS Lett. 1995;368:513-515.
12. Thong PSP, Selley M, Watt F. Elemental changes in atherosclerotic lesions using nuclear microscopy. Cell Mol Biol. 1996;42:103-110.
13. Pinheiro T, Pallon J, Fernandes R, Halpern MJ, Homman P, Malmqvist K. Nuclear microprobe applied to the study of coronary artery walls-a distinct look at atherogenesis. Cell Mol Biol. 1996;42:89-102.
14. Yuan XM, Li W, Olsson AG, Brunk UT. Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis. Atherosclerosis. 1996;124:61-73.
15. Sullivan JL. Iron and sex difference in heart disease risk. Lancet. 1981;1:1293-1294.
16. Danesh J, Appleby P. Coronary Heart Disease and Iron Status: Meta-Analyses of Prospective Studies. Circulation. 1999;99:852-854.
17. de Valk B, Marx JJ. Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med. 1999;159:1542-1548.
18. Horwitz LD, Rosenthal EA. Iron-mediated cardiovascular injury. Vasc Med. 1999;4:93-99.
19. Lamb DJ, Mitchinson MJ, Leake DS. Transition metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages. FEBS Lett. 1995;374:12-16.
20. Evans PJ, Smith C, Mitchinson MJ, Halliwell B. Metal ion release from mechanically-disrupted human arterial wall. Implications for the development of atherosclerosis. Free Rad Res. 1995;23:465-469.
21. Lee FY, Lee TS, Pan CC, Huang AL, Chau LY. Colocalization of iron and ceroid in human atherosclerotic lesions. Atherosclerosis. 1998;138:281-288.
22. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Arterioscler Thromb Vasc Biol. 1995;15:1512-1531.
23. Keyer K, Imlay JA. Superoxide accelerates DNA damage by elevating free-iron levels. Proc Natl Acad Sci USA. 1996;93:13635-13640.
24. Srinivasan C, Liba A, Imlay JA, Valentine JS, Gralla EB. Yeast lacking superoxide dismutase(s) show elevated levels of "Free Iron" as measured by whole cell electron paramagnetic resonance. J Biol Chem. 2000;275:29187-29192.
25. Knott HM, Baoutina A, Davies MJ, Dean RT. Comparative kinetics of copper-ion-mediated protein and lipid oxidation in low-density lipoprotein. Arch Biochem Biophys. 2002;400:223-232.
26. Symons MCR: Chemical and Biochemical Aspects of Electron Spin Resonance Spectroscopy. London: Wiley; 1978:1-190.
27. Swartz HM, Bolton JR, Borg DC: Biological Applications of Electron Spin Resonance. New York: Wiley; 1972:1-569.
28. Butcher GP, Deighton N, Batt RM, Ding B, Haywood S, Hoffman J, Jackson MJ, Symons MC, Rhodes JM. Electron paramagnetic resonance spectroscopy of stable free radicals in the liver compared with ultra-structural and functional damage in a rat model of alcohol- and iron-overload. Clin Sci (Colch). 1993;84:339-348.
29. Yuan XM, Brunk UT. Iron and LDL-oxidation in atherogenesis. APMIS. 1998;106:825-842.
30. Cichocki T, Heck D, Jarczyk L, Rokita E, Strzalkowski A, Sych M. Elemental composition of the human atherosclerotic artery wall. Histochemistry. 1985;83:87-92.
31. Watt F, Ren MQ, Xie JP, Tan BKH, Halliwell B: Nuclear microscopy of atherosclerotic tissue: A review. Nucl Instr Meth. 2001;B181:431-436.
32. Minqin R, Watt F, Tan Kwong Huat B, Halliwell B. Correlation of iron and zinc levels with lesion depth in newly formed atherosclerotic lesions. Free Radic Biol Med. 2003;34:746-752.
33. Lamb DJ, Avades TY, Ferns GA. Biphasic modulation of atherosclerosis induced by graded dietary copper supplementation in the cholesterol-fed rabbit. Int J Exp Pathol. 2001;82:287-294.
34. Harel S, Salan MA, Kanner J. Iron release from metmyoglobin, methaemoglobin and cytochrome c by a system generating hydrogen peroxide. Free Radic Res. 1988;5:11-19.
35. Siow RC, Sato H, Mann GE. Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide? Cardiovasc Res. 1999;41:385-394.
36. Nakayama M, Takahashi K, Komam T, Fukuchi M, Shioiri H, Sato K, Kitamuro T, Shirato K, Yamaguchi T, Suematsu M, Shibahara S. Increased expression of heme oxygenase-1 and bilirubin accumulation in foam cells of rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2001;21:1373-1377.
37. Pang J-HS, Jiang M-J, Chen Y-L, Wang F-W, Wang DL, Chu S-H, Chau L-Y: Increased ferritin gene expression in atherosclerotic lesions. J Clin Invest. 1996;97:2204-2212.
38. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, Narula J, Finn AV, Virmani R. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med. 2003;349:2316-2325.
39. Heinecke JW, Rosen H, Chait A. Iron and copper promote modification of low density lipoprotein in vitro by free radical oxidation. J Clin Invest. 1984;74:1890-1894.
40. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
41. Kritharides L, Jessup W, Dean RT. Macrophages require both iron and copper to oxidize low-density lipoprotein in Hanks' balanced salt solution. Arch Biochem Biophys. 1995;323:127-136.
42. 2. J Biol Chem. 1992;267:23646-23651.
43. Hawkins CL, Davies MJ. Oxidative damage to collagen and related substrates by metal ion / hydrogen peroxide systems: random attack or site-specific damage? Biochim Biophys Acta. 1997;1360:84-96.
44. Vissers MC, Winterbourn CC. The effect of oxidants on neutrophil-mediated degradation of glomerular basement membrane collagen. Biochim Biophys Acta. 1986;889:277-286.
45. Weiss SJ, Curnutte JT, Regiani S. Neutrophil-mediated solubilization of the subendothelial matrix: oxidative and nonoxidative mechanisms of proteolysis used by normal and chronic granulomatous disease phagocytes. J Inummol. 1986;136:636-641.
46. McGowan SE, Murray JJ. Direct effects of neutrophil oxidants on elastase-induced extracellular matrix proteolysis. Am Rev Respir Dis. 1987;135:1286-1293.
47. Mattana J, Margiloff L, Chaplia L. Oxidation of extracellular matrix modulates susceptibility to degradation by the mesangial matrix metalloproteinase-2. Free Radic Biol Med. 1999;27:315-321.
48. Davies MJ, Thomas AC. Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death and crescendo angina. Br Heart J. 1985;53:363-373.
49. Libby P, Schoenbeck U, Mach F, Selwyn AP, Ganz P: Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization. Am J Med. 1998;104:14S-18S.
50. Woods A, Linton SM, Davies MJ. Detection of HOC1-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques. Biochem J. 2003;370:729-735.